RXO Inc: UBS raises target price to $30.25 from $23
RXO•UBS raised its target price for RXO to $30.25 from $23.
Related News
UBS raises Pfizer target price to $30 from $27
PFE•
Gartner, Inc.: UBS raises target price to $220 from $208
IT•
OneMedNet receives mid-six-figure repeat order from radiology AI company
ONMD•
BWX Technologies launches cash tender offers for $800 million in senior notes
BWXT•
Dynatrace target price cut to $75 from $80 by UBS
DT•